Nextgen Biomed Ltd (TLV:NXGN)
48.70
+3.70 (0.62%)
Sep 30, 2025, 5:24 PM IDT
Nextgen Biomed Market Cap
Nextgen Biomed has a market cap or net worth of 5.62 million as of October 7, 2025. Its market cap has decreased by -14.02% in one year.
Market Cap
5.62M
Enterprise Value
5.68M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
48.70
Market Cap Chart
Since July 17, 2013, Nextgen Biomed's market cap has decreased from 18.97M to 5.62M, a decrease of -70.37%. That is a compound annual growth rate of -9.48%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 30, 2025 | 5.62M | -14.06% |
Dec 31, 2024 | 6.54M | -28.83% |
Dec 31, 2023 | 9.19M | -66.19% |
Dec 29, 2022 | 27.18M | -55.05% |
Dec 30, 2021 | 60.47M | -24.05% |
Dec 31, 2020 | 79.61M | 936.11% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 75.93B |
Danel (Adir Yeoshua) | 3.00B |
Kamada | 1.33B |
Bait Bakfar | 974.87M |
BrainsWay | 961.20M |
SofWave Medical | 943.38M |
Ilex Medical | 747.81M |
Novolog (Pharm-Up 1966) | 661.07M |